Application of the Quality by Design Principles for the Development of the Crystallization Process for a Piperazinyl-Quinoline and Definition of the Control Strategy for Form 1

被引：2

作者：

Cimarosti, Zadeo ^{[1
]}

Rossi, Sara ^{[1
]}

Tramarin, Davide ^{[1
]}

Laval, Gilles ^{[1
]}

Stabile, Paolo ^{[1
]}

Giubellina, Nicola ^{[1
]}

Maton, William ^{[1
]}

Allieri, Brigida ^{[2
]}

Campi, Francesca ^{[2
]}

Cooke, Jason ^{[3
]}

Westerduin, Pieter ^{[1
]}

机构：

[1] GlaxoSmithKline Med Res Ctr, Chem Dev, I-37135 Verona, Italy

[2] GlaxoSmithKline Med Res Ctr, Pharmaceut Dev, I-37135 Verona, Italy

[3] GlaxoSmithKline, Med Res Ctr, Chem Dev, Stevenage, Herts, England

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2012年 / 16卷 / 10期

关键词：

ANTIDEPRESSANTS; DERIVATIVES; DIHYDRATE;

D O I：

10.1021/op300126e

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

The studies carried out to develop a robust crystallization method for the substituted piperazinyl-quinoline (1) a compound potentially active in the treatment of depression, are described in this contribution. These studies include the control of a solvate that could have potentially formed in the crystallization process. The principles of quality by design (QbD) were applied to generate the process understanding and to define the control strategy for the control of the formation of the solvate during the crystallization. The application of process analytical technology (PAT) tools was key in achieving the desired process control.

引用

页码：1598 / 1606

页数：9

共 16 条

[1] Application of Quality by Design Principles for the Definition of a Robust Crystallization Process for Casopitant Mesylate
Castagnoli, Carlo
Yahyah, Mohammed
Cimarosti, Zadeo
Peterson, John J.
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2010, 14 (06) : 1415 - 1427
[2] Application of Quality by Design Principles to Support Development of a Control Strategy for the Control of Genotoxic Impurities in the Manufacturing Process of a Drug Substance
Cimarosti, Zadeo
Bravo, Fernando
Stonestreet, Paul
Tinazzi, Francesco
Vecchi, Orsola
Camurri, Giulio
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2010, 14 (04) : 993 - 998
[3] Application of a Statistical Approach to Process Development of Futibatinib by Employing Quality-by-Design Principles. Part 3: Development of Design Space for Control of Particle Size Distribution
Abe, Yasunori
Emori, Kosuke
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (01) : 72 - 81
[4] Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein
Looby, Mairead
Ibarra, Neysi
Pierce, James J.
Buckley, Kevin
O'Donovan, Eimear
Heenan, Mary
Moran, Enda
Farid, Suzanne S.
Baganz, Frank
BIOTECHNOLOGY PROGRESS, 2011, 27 (06) : 1718 - 1729
[5] Application of a Statistical Approach to Process Development of Futibatinib by Employing Quality-by-Design Principles. Part 1: Identification of Critical Process Parameters for Impurities
Abe, Yasunori
Emori, Kosuke
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (01) : 43 - 55
[6] Control of product quality in batch crystallization of pharmaceuticals and fine chemicals. Part 1: Design of the crystallization process and the effect of solvent
Rohani, S
Horne, S
Murthy, K
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2005, 9 (06) : 858 - 872
[7] Impact of Quality by Design in Process Development on the Analytical Control Strategy for a Small-Molecule Drug Substance
Bryan C. Castle
Robert A. Forbes
Journal of Pharmaceutical Innovation, 2013, 8 : 247 - 264
[8] Impact of Quality by Design in Process Development on the Analytical Control Strategy for a Small-Molecule Drug Substance
Castle, Bryan C.
Forbes, Robert A.
JOURNAL OF PHARMACEUTICAL INNOVATION, 2013, 8 (04) : 247 - 264
[9] Production and comprehensive quality control of recombinant human Interleukin-1β:: A case study for a process development strategy
Block, Helena
Kubicek, Jan
Labahn, Joerg
Roth, Udo
Schaefer, Frank
PROTEIN EXPRESSION AND PURIFICATION, 2008, 57 (02) : 244 - 254
[10] Application of a Statistical Approach to the Process Development of Futibatinib by Employing Quality-by-Design Principles. Part 2: Development of Design Space for Impurities Using the Response Surface Methodology
Abe, Yasunori
Emori, Kosuke
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (01) : 56 - 71

← 1 2 →